About Healthcare News
Novo CEO pressed by Senate to cut price ranges of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into consideration new talks with insurers about the record selling prices of Wegovy and copyright when they pledge to keep the medicines on their formularies.The offer have to be done by Sept.